The widening in the trade deficit to a new record high in March was driven entirely by imports of pharmaceutical products as firms looked to front-run tariffs. This was broadly in-line with the BEA’s assumption in its first-quarter GDP estimate, suggesting little revision to the 0.3% contraction for now.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.